BGDV
Bahl & Gaynor Dividend ETF
Bahl & Gaynor Dividend ETF seeks to provide investors with current income and long-term capital appreciation by investing primarily in high-quality dividend-paying stocks.
US
EQUITY
Active
MANAGEMENT STYLE
$ 882.8 M
ASSETS UNDER MGMT
45 bp
EXPENSES
Fund Basics
| Inception date | Dec 11, 2024 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| VICTORY CAPITAL HOLDING - A | 4.7 % |
| ELI LILLY & CO | 4.3 % |
| TAIWAN SEMICONDUCTOR-SP ADR | 3.8 % |
| MOTOROLA SOLUTIONS | 3.7 % |
| ABBVIE INC | 3.6 % |
| MICROSOFT CORP | 3.6 % |
| ENCOMPASS HEALTH CORPORATION | 3.4 % |
| UNITEDHEALTH GROUP INC | 3.0 % |
| CINTAS CORP | 2.9 % |
| NVIDIA CORP | 2.9 % |
Constituent Breakdown
| Number of holdings | 47 |
| Herfindahl-Hirschman Index | 254 |
| Wgt avg mkt cap (mns) | $662,201 |
| Large cap (>$10bn) | 95.2% |
| Mid cap ($2-10bn) | 4.7% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 96.1% |
| Emerging mkts. | 3.8% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 93.1 % |
 |
TAIWAN | 3.8 % |
 |
ITALY | 1.9 % |
 |
IRELAND | 1.1 % |
Historical Performance
Standardized Performance (as of 10/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 14.1% | 17.7% | -- | -- | -- | -- | -- | 12.9% |
| Dividend Yield | 0.9% | 1.2% | -- | -- | -- | -- | -- | 1.2% |
| Total Returns | 15.0% | 18.9% | -- | -- | -- | -- | -- | 14.2% | Ann. Volatility | 10.9% | 10.9% | -- | -- | -- | -- | -- | 14.0% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.71 | 70% |
| MSCI EAFE | 0.52 | 57% |
| MSCI Emg Mkts | 0.28 | 44% |
Liquidity Measures
| Avg. volume (000) | 16 |
| ADV traded (mns) | $1 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.08% |
Technical Indicators
| 30d moving avg. (EMA) | $30.97 |
| Relative strength (RSI) | 46 |
| MACD/Signal | 0.06/0.12 |
| Bollinger Bands (Upper/Lower) | $31.63/$30.49 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. BGDV |
Expenses vs. BGDV |
ALTAR Score™ vs. BGDV |
|---|---|---|---|---|
| BGIG | Bahl & Gaynor Income Growth ETF | 40.0% | 0 bp | +0.8% |
| CGCV | Capital Group Conservative Equity ETF | 31.7% | -12 bp | +0.4% |
| HQDG | Raub Brock Dividend Growth ETF | 30.9% | +5 bp | +0.1% |
| BDIV | AAM Brentview Dividend Growth ETF | 29.9% | +4 bp | +0.0% |
| CGUS | Capital Group Core Equity ETF | 29.4% | -12 bp | 0.0% |
| SQS | Sapient Quality Select ETF | 29.3% | +35 bp | -0.9% |
| JGRW | Jensen Quality Growth ETF | 27.8% | +12 bp | +0.1% |
| RFFC | ALPS Active Equity Opportunity ETF | 27.6% | +3 bp | 0.0% |
| DYNF | BlackRock U.S. Equity Factor Rotation ETF | 27.5% | -19 bp | +0.5% |
| FDLO | Fidelity Low Volatility Factor ETF | 27.3% | -30 bp | +0.9% |
Risk and Returns: BGDV vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/13/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.6%
ALTAR SCORE™
33rd
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,439 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. BGDV's ALTAR Score™ is approximately -0.5 standard
deviations above the category average. This places BGDV in the 33rd percentile
among funds in the category.
Sell-Side Consensus
$36.79
PRICE TARGET
+16.3%
UPSIDE